Viral Diseases and Immunity

Kaposi's sarcoma, psoriasis, and eczema are all common skin problems that can occur in people with HIV/AIDS. Kaposi's sarcoma is a type of cancer that causes purple or red lesions to appear on the skin. Psoriasis is a chronic skin condition that causes red, scaly patches of skin to appear on the body. Eczema is a skin condition that causes dry, itchy skin.

All of the above options can be effective in treating Kaposi's sarcoma in people with HIV/AIDS. Radiation therapy can help to shrink tumors. Chemotherapy can help to kill cancer cells. And antiretroviral therapy can help to suppress the HIV virus and improve the immune system, which can help to slow the growth of Kaposi's sarcoma tumors.

Children under the age of 5, people who have not been vaccinated, and people who live in unsanitary conditions are all at increased risk of getting polio.

The number of cases of polio has decreased by over 99% since 1988, polio has been eradicated from most countries in the world, and a vaccine for polio has been developed.

Individuals can help the GPEI in its efforts to eradicate polio by getting vaccinated against polio, donating to the GPEI, and spreading awareness about polio.

Viruses can use various mechanisms to evade the immune system, including molecular mimicry, antigenic shift, and latency. Molecular mimicry involves the virus mimicking host molecules to avoid recognition by the immune system. Antigenic shift refers to the ability of some viruses to change their surface proteins, making them unrecognizable to the immune system. Latency is a state in which the virus remains dormant within the host, evading immune detection.

Viral glycoproteins play a crucial role in the initial attachment of the virus to host cells, facilitating viral entry and infection. They are not primarily involved in immune recognition and neutralization, viral replication, or assembly.

Influenza virus is a well-known example of a virus that undergoes antigenic shift. This process involves the reassortment of viral RNA segments, leading to the emergence of new viral strains with altered surface proteins. This allows the virus to evade pre-existing immunity and cause recurrent infections.

HIV employs multiple strategies to evade the immune system, including targeting CD4+ T cells. The virus expresses viral proteins that inhibit the function of CD4+ T cells, downregulates the expression of MHC class II molecules on infected cells, and induces apoptosis of CD4+ T cells. These mechanisms contribute to the depletion of CD4+ T cells and the development of AIDS.

Latency is a state in which the virus remains dormant within the host, evading immune detection. This allows the virus to persist in the host for extended periods without causing overt disease. During latency, the virus can prevent the immune system from recognizing and eliminating infected cells, and it can also facilitate the spread of the virus to new host cells.

Herpes simplex virus (HSV) is an example of a virus that establishes latency. After the initial infection, HSV can enter a latent state in sensory nerve ganglia. During latency, the virus remains dormant and evades the immune system. However, it can reactivate under certain conditions, leading to recurrent infections.

Molecular mimicry is a mechanism by which viruses evade the immune system by mimicking host molecules. This allows the virus to escape recognition by the immune system, interfere with the function of immune cells, and promote the survival of infected cells. Molecular mimicry can involve the imitation of host proteins, carbohydrates, or even MHC molecules.

Hepatitis B virus (HBV), human immunodeficiency virus (HIV), and cytomegalovirus (CMV) are all examples of viruses that use molecular mimicry to evade the immune system. HBV mimics host proteins to avoid recognition by the immune system. HIV mimics MHC molecules to interfere with the function of immune cells. CMV mimics host proteins to promote the survival of infected cells.

Viral interference is a phenomenon in which the replication of one virus in a cell prevents the replication of other viruses. This can occur through various mechanisms, such as the production of antiviral proteins, the degradation of viral RNA or DNA, or the inhibition of viral entry or assembly. By preventing the replication of other viruses, viral interference can contribute to the survival of the infecting virus and evade the immune system.

Herpes simplex virus (HSV) is an example of a virus that uses viral interference to evade the immune system. HSV can produce antiviral proteins that inhibit the replication of other viruses in infected cells. This can help HSV to establish and maintain latency, as well as to prevent superinfection by other viruses.